TokenPost·
Recursion Aligns With FDA on Late-Stage Trial Design for REC-4881

Recursion described the program as an early example of AI-assisted drug discovery pursuing a design intended to support registration.
Every crypto headline. One feed. Updated every minute.

Recursion described the program as an early example of AI-assisted drug discovery pursuing a design intended to support registration.